Clinical trial · Observational
Prevalence of COPD in Our Lung Cancer Population, Compared to Controls
Cross-sectional Study to Compare the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Patients Newly Diagnosed With Lung Cancer, Compared to Controls
NCT02603627CI-TRIAL-00019774unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will investigate the prevalence of chronic obstructive pulmonary disease (COPD) in patients who are newly diagnosed with lung cancer and compare it to the prevalence of COPD in controls recruited from a smoking cessation clinic.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| COPD | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Smoking | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- With lung cancer
- description
- Patients who have a new diagnosis of lung cancer will be invited to undergo spirometry to enable us to gather data on the prevalence of COPD in this group.
- label
- Without lung cancer
- description
- Smokers who are referred to the smoking cessation clinic will be invited to undergo spirometry to ascertain the prevalence of COPD in this group.
Primary outcomes (1)
- measure
- Prevalence of COPD in lung cancer compared to controls, using spirometry to diagnose COPD.
- timeFrame
- Up to nine months
Secondary outcomes (2)
- measure
- Comparison of the proportion of small cell tumours to non-small cell tumours in patients with lung cancer and COPD.
- timeFrame
- Up to nine months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Informed consent * Aged over 18 * Lung cancer group: new diagnosis of lung cancer, with spirometry results available Control group: spirometry result available or obtained Exclusion Criteria: * Patient refusal * Age under 18 * Control group: pre-existing lung cancer
References
Publications (0)
Data not yet available
No reference posted for this study.